Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
The length of time Americans with HIV remain infectious is falling, but slowly

In 2016, more than half of people with HIV in the United States took more than three years to be diagnosed, and more than five months after

Published
07 March 2019
By
Roger Pebody
Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women

Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from

Published
06 March 2019
By
Keith Alcorn
Atripla or efavirenz plus Truvada failed one in 16 people in first year

Estimates of how often people on antiretroviral therapy (ART) do not remain virally undetectable are important both in order to gauge the potency of ART, and to

Published
21 January 2019
By
Gus Cairns
Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

Published
16 January 2019
From
Science Daily
‘RAPID’ HIV treatment initiation a success in San Francisco

Populations considered hard to treat or engage in care can benefit from same-day antiretroviral treatment as part of a clinic offering social safety-net interventions.

Published
08 January 2019
From
AVERT
HIV treatment outcomes continue to get better, says large analysis

The efficacy of first-line antiretroviral therapy (ART) continues to improve, according to an analysis of outcomes in 78,000 people in 181 studies, published in AIDS by Professor

Published
27 December 2018
By
Michael Carter
HIV clinic's hardest battle in treating people is helping them to overcome the social stigma

Jason, who is using a pseudonym, is a heterosexual black man of African heritage. He is typical of the patients seen at the clinic in University Hospital Lewisham. There are 850 patients on the books, more than 50 per cent are heterosexual and most of African origin. Many live on the poverty line and struggle with mental health problems. But the biggest challenge facing the team is the issue of stigma.

Published
10 December 2018
From
Evening Standard
All people with HIV-2 should receive HIV treatment – without it, most will progress to AIDS and death

Most people with HIV-2 infection will progress to AIDS and death unless they receive antiretroviral therapy (ART), according to the results of a study conducted in Guinea-Bissau and

Published
27 November 2018
By
Michael Carter
Early HIV treatment reduces the risk of liver fibrosis

Early antiretroviral therapy (ART) reduces the risk of liver fibrosis progression in people living with HIV, including in people who do not have co-infection with viral hepatitis,

Published
08 November 2018
By
Michael Carter
← First12345...81Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.